SOP for statistical data sharing – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Mon, 29 Sep 2025 03:50:39 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Data Sharing with Regulators and Repositories https://www.clinicalstudies.in/sop-for-data-sharing-with-regulators-and-repositories/ Mon, 29 Sep 2025 03:50:39 +0000 ]]> https://www.clinicalstudies.in/?p=7045 Read More “SOP for Data Sharing with Regulators and Repositories” »

]]>
SOP for Data Sharing with Regulators and Repositories

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-data-sharing-with-regulators-and-repositories”
},
“headline”: “SOP for Data Sharing with Regulators and Repositories”,
“description”: “This SOP defines procedures for sharing clinical trial data with regulators and repositories, ensuring compliance with FDA, EMA, WHO, CDSCO, and ICH GCP guidelines. It includes data anonymization, formatting, submission portals, timelines, and retention requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Data Sharing with Regulators and Repositories

SOP No. CR/OPS/105/2025
Supersedes NA
Page No. 1 of 49
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to define procedures for the secure and compliant sharing of clinical trial data with regulators and public repositories. Data sharing enhances transparency, facilitates regulatory review, and supports global scientific collaboration while protecting subject confidentiality.

Scope

This SOP applies to sponsors, CROs, regulatory affairs, data management, statisticians, and QA staff responsible for preparing and submitting trial data. It covers sharing of clinical study reports (CSRs), patient-level data, anonymized datasets, safety data, and genomic or specialty datasets with regulatory authorities and repositories.

Responsibilities

  • Sponsor: Ensures data sharing obligations are met in line with regulatory requirements.
  • Regulatory Affairs: Manages submissions through portals such as FDA CDER NextGen, EMA Data Sharing, and WHO ICTRP repositories.
  • Data Management: Prepares anonymized datasets and metadata for submission.
  • Statisticians: Generate analysis outputs and ensure integrity of statistical datasets.
  • QA: Conducts QC checks on data packages prior to submission.

Accountability

The Sponsor’s Regulatory Head is accountable for ensuring accurate and timely data sharing with regulators and repositories. QA is accountable for verifying data integrity and compliance with GCP and privacy regulations.

Procedure

1. Planning
1.1 Develop Data Sharing Plan outlining obligations, datasets, repositories, and timelines.
1.2 Maintain Data Sharing Plan Log (Annexure-1).

2. Data Preparation
2.1 Extract data post-database lock.
2.2 Anonymize patient-level data in compliance with GDPR and HIPAA.
2.3 Prepare standardized datasets (e.g., CDISC SDTM, ADaM).
2.4 Maintain Data Preparation Log (Annexure-2).

3. Regulatory Submissions
3.1 Submit datasets through regulatory portals (FDA, EMA, CDSCO).
3.2 Upload supporting documents such as CSR, protocols, and SAP.
3.3 Maintain Regulatory Submission Log (Annexure-3).

4. Repository Sharing
4.1 Share trial data with WHO ICTRP and approved repositories where applicable.
4.2 Document repository submissions in Repository Sharing Log (Annexure-4).

5. Quality Control
5.1 QA verifies completeness, accuracy, and anonymization adequacy of data packages.
5.2 Document QC in Data Sharing QC Log (Annexure-5).

6. Archiving
6.1 Archive submitted datasets, logs, and confirmation receipts in TMF.
6.2 Retain in compliance with global archiving standards.

Abbreviations

  • SOP: Standard Operating Procedure
  • CSR: Clinical Study Report
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • TMF: Trial Master File
  • CDISC: Clinical Data Interchange Standards Consortium
  • SDTM: Study Data Tabulation Model
  • ADaM: Analysis Data Model
  • EMA: European Medicines Agency
  • FDA: Food and Drug Administration
  • WHO: World Health Organization
  • CDSCO: Central Drugs Standard Control Organization
  • HIPAA: Health Insurance Portability and Accountability Act
  • GDPR: General Data Protection Regulation

Documents

  1. Data Sharing Plan Log (Annexure-1)
  2. Data Preparation Log (Annexure-2)
  3. Regulatory Submission Log (Annexure-3)
  4. Repository Sharing Log (Annexure-4)
  5. Data Sharing QC Log (Annexure-5)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Data Manager
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Regulatory Affairs

Annexures

Annexure-1: Data Sharing Plan Log

Date Trial ID Obligation Responsible Status
01/09/2025 Study-456 CSR + IPD Sharing Regulatory Affairs Planned

Annexure-2: Data Preparation Log

Date Dataset Activity Prepared By Status
05/09/2025 ADaM Efficacy Dataset Anonymized Data Manager Completed

Annexure-3: Regulatory Submission Log

Date Agency Data Package Submitted By Status
10/09/2025 FDA CSR + SDTM Datasets Regulatory Affairs Accepted

Annexure-4: Repository Sharing Log

Date Repository Data Shared Submitted By Status
15/09/2025 WHO ICTRP Anonymized IPD Data Manager Submitted

Annexure-5: Data Sharing QC Log

Date Package Reviewed By QC Findings Status
20/09/2025 EMA Data Package QA Officer No findings Approved

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Regulatory Affairs

For more SOPs visit: Pharma SOP

]]>